Topics

Rising Out-Of-Pocket Costs For Insulin Indicates Market Failure

07:29 EDT 22 Mar 2019 | Forbes

Diabetes patients' cost-sharing is increasing as PBMs and health plans are paying less for insulin products. While this situation defies logic, it reflects an imperfect market in which it's not necessarily in the PBMs' and health plans' interests to engage in a fully competitive marketplace.

Original Article: Rising Out-Of-Pocket Costs For Insulin Indicates Market Failure

NEXT ARTICLE

More From BioPortfolio on "Rising Out-Of-Pocket Costs For Insulin Indicates Market Failure"

Quick Search

Relevant Topic

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...